Jianqing Zhu Selected Research

Cytoreduction Surgical Procedures

12/2023	Pulmonary metastasectomy for recurrent metastatic ovarian cancer.
1/2022	Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.
1/2020	A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.
11/2019	Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
4/2013	Genotyping of stathmin and its association with clinical factors and survival in patients with ovarian cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianqing Zhu Research Topics

Disease

24	Ovarian Neoplasms (Ovarian Cancer) 06/2024 - 04/2013
23	Neoplasms (Cancer) 05/2024 - 04/2013
8	Disease Progression 12/2023 - 01/2020
5	Carcinoma (Carcinomatosis) 06/2024 - 09/2020
5	Ovarian Epithelial Carcinoma 06/2024 - 04/2013
5	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2023 - 07/2015
3	Neoplasm Metastasis (Metastasis) 12/2023 - 10/2015
3	Infections 12/2018 - 10/2014
2	Anemia 12/2022 - 01/2021
2	Nausea 12/2022 - 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2024
1	Body Weight (Weight, Body) 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2022
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2022
1	Residual Neoplasm 10/2021
1	Cadmium Poisoning (Itai Itai) 04/2021
1	Poisoning 04/2021
1	Neutropenia 01/2021
1	Leukopenia 01/2021
1	Ascites 01/2021
1	Fallopian Tube Neoplasms 09/2020
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 09/2020
1	Disease Resistance 05/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Hypochromic Anemia (Chlorosis) 12/2019
1	Carcinogenesis 01/2019
1	Endometrial Neoplasms (Endometrial Cancer) 01/2019
1	Thrombocytosis (Thrombocythemia) 06/2017
1	Stomach Neoplasms (Stomach Cancer) 01/2017
1	Multiple Organ Failure (MODS) 10/2015
1	Pain (Aches) 10/2015
1	Thrombocytopenia (Thrombopenia) 10/2015
1	Hemorrhage 10/2015
1	Genetic Predisposition to Disease (Genetic Predisposition) 07/2015

Drug/Important Bio-Agent (IBA)

16	PlatinumIBA 06/2024 - 04/2013
5	niraparibIBA 06/2024 - 01/2020
5	Proteins (Proteins, Gene)FDA Link 11/2023 - 10/2018
4	olaparibIBA 05/2024 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2021
4	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2024 - 01/2021
2	Poly Adenosine Diphosphate RiboseIBA 05/2024 - 12/2022
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2024 - 01/2021
2	penpulimabIBA 02/2024 - 10/2022
2	AntigensIBA 09/2023 - 01/2021
2	camrelizumabIBA 12/2022 - 01/2022
2	famitinibIBA 12/2022 - 01/2022
2	Immune Checkpoint InhibitorsIBA 10/2022 - 01/2022
2	fluzoparibIBA 01/2022 - 01/2021
2	AntioxidantsIBA 04/2021 - 12/2019
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2019
2	Mitochondrial DNA (mtDNA)IBA 12/2018 - 10/2014
2	MicroRNAs (MicroRNA)IBA 06/2018 - 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 02/2024
1	Glucose (Dextrose)FDA LinkGeneric 02/2024
1	Molecular Probes (Molecular Probe)IBA 01/2024
1	zimberelimabIBA 12/2023
1	Tumor Biomarkers (Tumor Markers)IBA 11/2023
1	Epithelial Cell Adhesion MoleculeIBA 11/2023
1	Programmed Cell Death 1 ReceptorIBA 01/2023
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 01/2023
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2023
1	LigandsIBA 01/2023
1	Immunoglobulin G (IgG)IBA 10/2022
1	pamiparibIBA 01/2022
1	Cisplatin (Platino)FDA LinkGeneric 10/2021
1	Cadmium Chloride (Cadmium Dichloride)IBA 04/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	RacivirIBA 09/2020
1	ZincIBA 05/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Long Noncoding RNAIBA 01/2019
1	Potassium Channels (Potassium Channel)IBA 01/2019
1	CarbohydratesIBA 10/2018
1	EnzymesIBA 10/2018
1	Indicators and Reagents (Reagents)IBA 06/2017
1	Dihydrotachysterol (AT 10)IBA 10/2015
1	HLA-DQB1 antigen (HLA DQB1)IBA 07/2015
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2015
1	16S Ribosomal RNAIBA 10/2014
1	DNA (Deoxyribonucleic Acid)IBA 04/2013
1	StathminIBA 04/2013

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 06/2024 - 04/2013
14	Therapeutics 06/2024 - 01/2017
5	Cytoreduction Surgical Procedures 12/2023 - 04/2013
3	Neoadjuvant Therapy 01/2023 - 09/2020
1	Metastasectomy 12/2023
1	Immunotherapy 01/2022
1	Brachytherapy 10/2021
1	Chemoradiotherapy 10/2021
1	Radiotherapy 10/2021
1	Hysterectomy 01/2017
1	Lymph Node Excision (Lymph Node Dissection) 01/2017
1	Punctures 10/2015
1	Salpingo-oophorectomy 10/2015